Fluctuation of intraocular pressure in glaucoma patients before and after trabeculectomy with mitomycin C
- PMID: 28977004
- PMCID: PMC5627910
- DOI: 10.1371/journal.pone.0185246
Fluctuation of intraocular pressure in glaucoma patients before and after trabeculectomy with mitomycin C
Abstract
Purpose: Intraocular pressure (IOP) fluctuation is considered as a risk factor for glaucoma progression. We investigated IOP values and IOP fluctuation before and after trabeculectomy (TE) with mitomycin C (MMC) measured by 48-hour diurnal-nocturnal-IOP-profiles (DNP).
Methods: Pre- and postoperative DNPs of 92 eyes undergoing primary TE with MMC were analysed. Each 48-hour IOP-profile involved 10 IOP measurements (8:00 a.m., 2:00 p.m., 6:00 p.m., and 9:00 p.m. in sitting and at 00:00 in supine position). The "preoperative DNP" was performed a few weeks before TE. The "postoperative DNP" was performed at least six months (range: 6 months-2 years) after TE. Mean IOP values and IOP fluctuations were calculated.
Results: After TE with MMC mean IOP was reduced from 16.94±3.83 to 11.26±3.77 mmHg at daytime and from 18.17±4.26 to 11.76±3.90 mmHg at night. At daytime mean IOP-fluctuation decreased from 8.61±4.19 to 4.92±2.52 mmHg, at night from 3.15±2.95 to 1.99±1.82 mmHg. Mean IOP was lower on the second day of the preoperative DNP. This effect was not present in the postoperative DNP. Preoperatively, IOP was controlled in all eyes with a mean of 3.22±0.94 antiglaucomatous agents. Postoperatively, IOP≤15 mmHg was achieved in 71.7%, IOP≤18 mmHg in 77.1% and a decrease in IOP of >30% in 47.8% without antiglaucomatous therapy. Postoperatively, pseudophakia was associated by a higher mean IOP-fluctuation compared to the phakic eyes.
Conclusions: TE with MMC significantly reduces both mean IOP-values and IOP- fluctuations at day and night at least 6 months postoperatively. The effect of TE on the IOP fluctuation was less pronounced in pseudophakic eyes.
Conflict of interest statement
Figures







Similar articles
-
Comparison of results of initial trabeculectomy with mitomycin C after prior clear-corneal phacoemulsification to outcomes in phakic eyes.J Glaucoma. 2013 Jan;22(1):52-9. doi: 10.1097/IJG.0b013e31821e8607. J Glaucoma. 2013. PMID: 21623217
-
Primary trabeculectomy with mitomycin C: safety and efficacy at 2 years.Clin Exp Ophthalmol. 2010 Dec;38(9):831-8. doi: 10.1111/j.1442-9071.2010.02349.x. Clin Exp Ophthalmol. 2010. PMID: 20572827
-
Deep sclerectomy with mitomycin C in failed trabeculectomy.Eye (Lond). 2007 Jan;21(1):23-8. doi: 10.1038/sj.eye.6702183. Epub 2005 Nov 25. Eye (Lond). 2007. PMID: 16311522
-
Trabeculectomy first in pseudophakic eyes requiring surgery for medically-uncontrolled glaucoma.Surv Ophthalmol. 2017 Jan-Feb;62(1):104-108. doi: 10.1016/j.survophthal.2016.05.004. Epub 2016 May 24. Surv Ophthalmol. 2017. PMID: 27233236 Review. No abstract available.
-
What happens to glaucoma patients during sleep?Curr Opin Ophthalmol. 2013 Mar;24(2):162-6. doi: 10.1097/ICU.0b013e32835c8a73. Curr Opin Ophthalmol. 2013. PMID: 23262987 Review.
Cited by
-
Role of 24-Hour Intraocular Pressure Monitoring in Glaucoma Management.J Ophthalmol. 2019 Sep 19;2019:3632197. doi: 10.1155/2019/3632197. eCollection 2019. J Ophthalmol. 2019. PMID: 31641532 Free PMC article. Review.
-
Advances in Canaloplasty-Modified Techniques Yield Strong Pressure Reduction with Low Risk Profile.J Clin Med. 2023 Apr 21;12(8):3031. doi: 10.3390/jcm12083031. J Clin Med. 2023. PMID: 37109367 Free PMC article. Review.
-
Standalone Implantation of 2-3 Trabecular Micro-Bypass Stents (iStent inject ± iStent) as an Alternative to Trabeculectomy for Moderate-to-Severe Glaucoma.Ophthalmol Ther. 2022 Feb;11(1):271-292. doi: 10.1007/s40123-021-00424-4. Epub 2021 Nov 25. Ophthalmol Ther. 2022. PMID: 34825352 Free PMC article.
-
Impact of intraocular pressure fluctuations on progression of normal tension glaucoma.Int J Ophthalmol. 2021 Oct 18;14(10):1553-1559. doi: 10.18240/ijo.2021.10.12. eCollection 2021. Int J Ophthalmol. 2021. PMID: 34667732 Free PMC article.
-
Efficacy and safety of XEN®-Implantation vs. trabeculectomy: Data of a "real-world" setting.PLoS One. 2020 Apr 20;15(4):e0231614. doi: 10.1371/journal.pone.0231614. eCollection 2020. PLoS One. 2020. PMID: 32310972 Free PMC article.
References
-
- Heijl A, Leske MC, Bengtsson B, Hyman L, Bengtsson B, Hussein M. Early Manifest Glaucoma Trial Group. Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial. Arch Ophthalmol 2002;120:1268–1279. - PubMed
-
- Coleman AL, Miglior S. Risk factors for glaucoma onset and progression. Survey of ophthalmology 2008;53 Suppl1: S3–10. - PubMed
-
- Asrani S, Zeimer R, Wilensky J, Gieser D, Vitale S, Lindenmuth K. Large diurnal fluctuations in intraocular pressure are an independent risk factor in patients with glaucoma. Journal of glaucoma 2000;9(2): 134–42. - PubMed
-
- Nouri-Mahdavi K, Hoffman D, Coleman AL, Liu G, Li G, Gaasterland D et al. Predictive factors for glaucomatous visual field progression in the Advanced Glaucoma Intervention Study. Ophthalmology 2004;111(9):1627–35. doi: 10.1016/j.ophtha.2004.02.017 - DOI - PubMed
-
- Bergea B, Bodin L, Svedbergh B. Impact of intracularpressure regulation on visual fields in open-angle glaucoma. Ophthlamology 1999;106:997–1004, discussion 1004–5. - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical